Advanced Wound Care Market Would Reach $22,088.6 Million by 2024
databridgemarketresearch.com presents new published report titled “Acelity L.P. Inc., Smith and Nephew and Mölnlycke Health Care are Dominated the Industry for Global Advanced Wound Care Market in 2017-2024”, also the Global Advanced Wound Care Market is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market
Acelity L.P. INC. is going to dominate the advanced wound care market in 2016 followed by Smith and Nephew, and Mölnlycke Health Care. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.
If you want to purchase this report kindly send the email @ Sales@databridgemarketresearch.com
ACELITY L.P. INC.:
Acelity L.P. Inc was founded in 1976 and headquartered in San Antonio, Texas; this company designs products to address needs in the areas of advanced wound therapy and regenerative medicine with best-in-class solutions that deliver superior clinical outcomes for patients. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Acelity L.P. Inc operates through two business segments: Advanced Wound Therapy (AWT) and Regenerative Medicine (RM).
Recent Developments:
- In February 2017, Acelity L.P. Inc. announced that it has completed the sale of its regenerative medicine business unit, Life cell Ccorporation to Allergen for USD 2.9 billion in cash.
- In October 2016, Acelity L.P. Inc. announced that Alloderm Select Duo Regenerative Tissue Matrix is launched in the United States. Alloderm Regenerative Tissue Matrix is the nation’s leading biological tissue matrix for soft tissue reinforcement.
Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-advanced-wound-care-market
SMITH AND NEPHEW:
Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.
Recent Developments:
- In December 2016, Smith and Nephew, the globalmedical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.
MOLNLYCKE HEALTHCARE:
Molnlycke was founded in 1849, and is headquartered in Gothenburg, Sweden. Mölnlycke Health Care is a world leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Company design and supply products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world.
Recent Developments:
- In February 2016, Molnlycke announced the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.
View Full Report Visit @ http://databridgemarketresearch.com/reports/global-advanced-wound-care-market/
TABLE OF CONTENTS:
- INTRODUCTION
- MARKET SEGMENTATION
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
- GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
- GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
- GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
- GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
10.3. APAC ADVANCED WOUND CARE MARKET
10.5. EUROPE ADVANCED WOUND CARE MARKET
10.6. MEA ADVANCED WOUND CARE MARKET
- GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA
- COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLI
12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTF
12.4.4. RECENT DEVELOPMENTS
12.5. 3M
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. BAXTER
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. COLOPLAST
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
12.11.1. COMPANY OVERVIEW
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
12.12.1. COMPANY OVERVIEW
12.12.2. REVENUE ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. RECENT DEVELOPMENTS
Related Report
Global Tumour Ablation Market – Trends and Forecast to 2024
Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research